Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Mabs|July 19, 2019
Binding symmetry and surface flexibility mediate antibody self-associationJoseph D Schrag, Marie-Ève Picard, Francis Gaudreault, et al.Cancer Research|October 28, 1999
Germ-line msh6 mutations in colorectal cancer familiesR D Kolodner, J D Tytell, J L Schmeits, et al.Cancer Research|July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive historyT R Rebbeck, Y Wang, P W Kantoff, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 10, 2023
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall periodM K Lee, E Basch, S A Mitchell, et al.Structure (London, England : 1993)|February 15, 1997
The open conformation of a Pseudomonas lipaseJ D Schrag, Y Li, M Cygler, et al.Journal of the National Cancer Institute|September 2, 1999
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriersT R Rebbeck, A M Levin, A Eisen, et al.Science (New York, N.Y.)|January 5, 2000
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndromeD W Bell, J M Varley, T E Szydlo, et al.European Radiology|November 22, 2011
Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancerM J Gollub, D H Gultekin, O Akin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2018
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancersN J Birkbak, Y Li, S Pathania, et al.Cancer Research|November 24, 2001
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni SyndromeS B Lee, S H Kim, D W Bell, et al.Pageof 15